Hospital-to-Home: helping kids with asthma stay out of the hospital
Official title: The Hospital to Home Study: A Pragmatic Trial to Optimize Transitions and Address Disparities in Asthma Care
Funded at Children's Research Institute · NIH-11289367 · Data updated 2026-11-12
A pragmatic trial tests a patient-centered program to improve asthma care for children after hospitalization, aiming to reduce readmissions and disparities.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Research Institute NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | January 1, 2023 |
| Project end | December 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $873,267 |
| NIH project number | 5R01HL161665-04 |
| Project ID | NIH-11289367 on NIH RePORTER |
Who could benefit from this research
✓Could help
Children hospitalized for asthma, especially those from under-resourced backgrounds, and their families.
✕Less likely to help
Children with asthma who do not require discharge planning or live in settings not served by the participating hospitals may see fewer direct benefits.
What this research studies
This project tests a multicomponent program delivered at both children’s and community hospitals to support families after a child’s asthma hospitalization. It includes navigation help, giving medications at discharge, coordinating with primary care, school-based therapy, and home assessments, with telehealth to connect stakeholders. The study uses real-world hospital settings and follows children for 12 months to see if the program reduces readmissions and improves outcomes for under-resourced families. Researchers will gather feedback from families, clinicians, and schools to refine the intervention for broad use. The goal is to identify practical ways to implement the program so more kids with asthma can stay healthy at home and in school.
Why it matters
Potential benefit: If successful, the program could lower hospital visits and improve daily life for children with asthma and their families.
How similar studies have gone: Prior similar programs have shown promise in reducing readmissions, but this pragmatic approach aims to test real-world effectiveness and implementation.
Where this research is happening
-
Children's Research Institute
Washington, United States Active
Researchers
- Principal investigator: Parikh, Kavita — Children's Research Institute
- Study coordinator: Parikh, Kavita
Related research
Other NIH-funded projects on the same topics.
-
GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults
Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.
-
Understanding how a type of immune cell called ILC2s affect asthma in adults
This grant studies how group 2 innate lymphoid cells influence asthma in adults to help identify new ways to manage airway inflammation.
-
Expanding understanding of asthma in kids through airways and blood profiling
A study at UC San Francisco will profile blood and nasal/sputum samples from 300 youth (including 200 with asthma) over a year to understand how environmental and social factors influence asthma in marginalized communities.
-
Preventing and improving asthma care for children in urban communities
This program will try several approaches — from giving helpful bacteria to babies to allergy immunotherapy and advanced airway testing — to prevent and better treat asthma in children who live in cities.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.